Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Common Equity (2016 - 2025)

Alkermes (ALKS) has disclosed Common Equity for 16 consecutive years, with $1.8 billion as the latest value for Q4 2025.

  • On a quarterly basis, Common Equity rose 24.19% to $1.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 billion, a 24.19% increase, with the full-year FY2025 number at $1.8 billion, up 24.19% from a year prior.
  • Common Equity was $1.8 billion for Q4 2025 at Alkermes, up from $1.7 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $1.8 billion in Q4 2025 to a low of $1.0 billion in Q1 2023.
  • A 5-year average of $1.3 billion and a median of $1.2 billion in 2023 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: dropped 6.49% in 2023, then soared 34.16% in 2025.
  • Alkermes' Common Equity stood at $1.1 billion in 2021, then fell by 6.19% to $1.0 billion in 2022, then rose by 15.23% to $1.2 billion in 2023, then increased by 21.81% to $1.5 billion in 2024, then increased by 24.19% to $1.8 billion in 2025.
  • Per Business Quant, the three most recent readings for ALKS's Common Equity are $1.8 billion (Q4 2025), $1.7 billion (Q3 2025), and $1.6 billion (Q2 2025).